Compare PLSE & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | MD |
|---|---|---|
| Founded | 2014 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.0B |
| IPO Year | 2016 | 1995 |
| Metric | PLSE | MD |
|---|---|---|
| Price | $14.15 | $21.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $22.00 | $21.00 |
| AVG Volume (30 Days) | 180.7K | ★ 993.4K |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | $86,000.00 | ★ $1,922,442,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,002.94 | $2.70 |
| P/E Ratio | ★ N/A | $11.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $11.84 |
| 52 Week High | $25.00 | $24.99 |
| Indicator | PLSE | MD |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 48.88 |
| Support Level | $14.33 | $21.35 |
| Resistance Level | $15.96 | $22.19 |
| Average True Range (ATR) | 0.71 | 0.61 |
| MACD | 0.12 | -0.15 |
| Stochastic Oscillator | 29.02 | 39.03 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.